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The effect of universal maternal antenatal
iron supplementation on
neurodevelopment in offspring: a
systematic review and meta-analysis
C. Jayasinghe1* , R. Polson2, H. C. van Woerden2 and P. Wilson3
Abstract
Background: Although antenatal iron supplementation is beneficial to mothers, its impact on the neurodevelopment
of offspring is controversial. A systematic review and meta-analysis was undertaken to assess whether routine maternal
antenatal iron supplementation confers later neurodevelopmental benefit to offspring.
Methods: Electronic databases were searched using MESH terms or key words and identified papers were reviewed by
two independent reviewers. The study quality was assessed using the Cochrane risk of bias assessment tool. The
review was registered in the PROSPERO CRD data base.
Results: Seven publications were identified, based on four randomised trials published between 2006 and 2016. Three
of the trials were in the Asian sub-continent. A range of tools were used to evaluate neurodevelopment. Meta-analysis of
outcomes from the three RCTs meeting our inclusion criteria showed minimal effect of antenatal iron supplementation
on the neurodevelopment of offspring, which was not statistically significant: weighted mean difference of 0.54 (95% CI:
-0.67 to 1.75); test for overall effect Z = 0.87; p= 0.38; and heterogeneity 48%. Meta-analysis of outcomes of these RCTs at
later stages of development produced similar results.
Conclusions: The benefit of routine antenatal iron supplementation on neurodevelopment in offspring was not
statistically significant in this relatively limited set of trials, and some benefit cannot be excluded in areas with a high
prevalence of maternal anaemia. A large randomized controlled trial showing significant benefit would be required to
modify our conclusions.
Keywords: Iron supplementation, Antenatal, Offspring, Neurodevelopment, Iron deficiency anaemia
Background
Iron supplementation during pregnancy is routinely pro-
vided in many countries. The WHO currently recom-
mends that 30–60 mg of elemental iron is given daily
from as early as possible during pregnancy [1]. This pub-
lic health policy aims to improve pregnancy outcomes
and to reduce maternal anaemia [2, 3]. The beneficial
effect of iron supplementation during the antenatal
period in relation to birth weight, physical growth and
perinatal mortality has been evaluated in several studies
[2, 4]. An association has been shown between poor per-
formance in mental and psychomotor tests and lower
iron status in utero [5]. A randomized trial conducted in
Bangladesh supplementing iron in various doses, and
providing multiple micronutrients in food items for
antenatal mothers, did not shown any significant effect
on motor development of offspring at seven months old
[6]. However, a finding of the northern Finnish birth co-
hort of 1966 was that low maternal haemoglobin levels
in the final stage of pregnancy was linked to poorer edu-
cational achievement of offspring [7]. Another study
showed that antenatal iron and folic acid supplementa-
tion reduced the prevalence of anaemia from 67% to 38.
4%, and that there was an inverted U shaped relationship
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between maternal haemoglobin concentration and
motor function of one year old children [8]. Antenatal
supplementation with multiple micro-nutrients includ-
ing iron and folic acid has been shown to improve motor
and cognitive function of offspring at 3.5 years more ef-
fectively than supplementation with iron and folic acid
alone [9]. These studies give rise to the question as to
whether antenatal iron supplementation on its own leads
to better neurodevelopment in offspring, which is the
focus of this review.
The uncertainty in current evidence has been recog-
nised by previous researchers who have recommended
that the long term effects on child development of iron
supplementation during pregnancy should be assessed as
an area of priority [10–12]. The last available review of
the effect of iron supplementation in non-anaemic preg-
nant women, infants and young children on mental per-
formance and psychomotor development of children
was only able to include one randomised controlled trial
(RCT), which was undertaken in Australia and was in-
conclusive [13]. We have therefore undertaken a system-
atic review of the literature to examine the effect of iron
supplementation in pregnancy on neurodevelopment in
offspring. Neurodevelopment has been defined in this
context to include aspects of behaviour, cognitive develop-
ment, mental development or intellectual development.
Methods
Search strategy
Electronic databases, namely Ovid Medline, EMBASE,
CINAHL, SCOPUS, Cochrane Central Register of Con-
trolled Trials (CENTRAL), and Web of Science were
searched between 5th January and 10th February 2016.
The review included randomised controlled trials and
cohort studies reporting on the routine use of iron sup-
plementation during pregnancy and associated assessment
of child development as an outcome. The inclusion of co-
hort studies is in line with best practice where published
evidence is very sparse [14]. Non-randomized observational
studies were not included to minimize the risk of selection
bias and confounding (we found no such studies in our lit-
erature searches in any case). Both medical subject head-
ings and free text keywords were utilised as search terms.
In this review, synonyms for the term ‘child development’
included ‘children’s brain development’, ‘IQ’, ‘cognitive, psy-
chomotor or behavioural development’ (See search criteria
in the Additional file 1). Although we planned to include
cohort studies and of iron supplementation in pregnancy
followed by assessment of child development, in addition
to RCTs, none fulfilled the inclusion criteria.
Papers reporting the outcome of interest using any
type of neurodevelopmental assessment tools were ac-
cepted for the review. The references in the identified ar-
ticles and in related review articles were manually
searched for additional literature that might otherwise
have been missed by the electronic databases. The
review included only original research articles published
as full text in the English language and conducted on
human beings.
Inclusion criteria
The inclusion criteria were: RCTs and cohort studies,
reporting the association between iron supplementation
during pregnancy and neurodevelopment in offspring
undertake before the offspring had reached puberty, in
practice, 12 years of age. Iron supplementation had to be
the key difference between at least one intervention
group and one control group.
PICO [15, 16] definitions:
Population: Pregnant women
Intervention: Iron supplementation (or iron with a
micronutrient, where the comparator was the
micronutrient alone)
Comparator: Placebo supplementation, or no
supplementation, or micronutrient supplementation
but without iron or ferrous compounds
Outcome: Child neurodevelopment, including mental
development, cognitive function, psychomotor
development, IQ, behaviour or other aspects of
neurodevelopment
Study selection
Titles and abstracts retrieved from the search were
jointly assessed by two reviewers (JC & HvW) for eligi-
bility by reading titles and, where appropriate, abstracts.
Studies that were obviously irrelevant were excluded. A
study selection flow diagram is shown in Fig. 1 based on
the PRISMA tool [17]. The full text of potentially rele-
vant remaining articles was assessed by one reviewer,
with review by a second person, to establish final eligi-
bility. An update of the literature search was carried out
to 30th July 2016. One study published in May 2016 was
found and was included in the review [18].
Data extraction and quality review process
Data from the included studies are summarized in
Table 1. A data extraction instrument designed in line
with Cochrane data extraction sheets was used [19],
which included the author, title, journal, year of publica-
tion, study setting, study design, study population, sam-
ple size, participants’ characteristics, country where the
research was carried out, type of iron supplementation,
definition of iron deficiency anaemia, the method or tool
used to assess child development, follow up period and
study outcomes relevant to the review. Key data from
each of the selected studies were at first reviewed inde-
pendently by two reviewers (JC & HvW) and then jointly
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for quality assessment using the Cochrane Risk of
Bias check list [2]. Discrepancies were forwarded for
arbitration to the third reviewer (PW). We had only
two disagreements regarding the blindness of inter-
vention group of the participants in Parsons et el.
[20] and inclusion of a Mendelian randomization
study for the review [21]. Risk of bias was rated as
high, low or unclear (see Fig. 2).
Analysis
A meta-analysis was undertaken using Review Manager
5.3 [22]. Studies were excluded from the meta-analysis if
they included the same participants who had been re-
ported in another included paper. Where several studies
followed up the same group of participants, the study
entered into the meta-analysis was that with the length
of follow up that was closest to other included studies.
Forest plots were created using Review Manager and
weighted mean differences were calculated.
A random effects model was used, as there was a po-
tential for heterogeneity arising out of the range of as-
sessment methods used by the included studies. Under
such circumstances this is more robust than using a
fixed effects model. The review was registered in the
PROSPERO CRD data base, registration number CRD
42016037114.
Results
A total of 324 articles were identified by searching elec-
tronic databases and a further two were identified by
manual bibliographic searches (Fig. 1). Of those, 270 ar-
ticles were excluded during initial screening because
they did not report the effect of iron supplementation
on child neurodevelopment. The full texts of the
remaining 56 articles were again reviewed to assess
whether their research objectives met our inclusion cri-
teria. This full text review led to exclusion of a further
42 articles as the outcome of interest was outside the
scope of our objectives. Hence, 15 articles were selected
by both reviewers, one of which was excluded because
the intervention included both iron and folic acid [12].
Six articles were excluded as they assessed different
doses of antenatal iron but did not utilise a control
group who did not receive a supplement [6–9, 23, 24].
One Mendelian randomization study was removed be-
cause final analysis was undertaken according to the
Fig. 1 PRISMA Flow diagram for identified studies
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genetic variant and the effect of iron supplementation or
non-supplementation could not be established [21]. The
remaining seven articles were included in the qualitative
synthesis (Fig. 1).
Study characteristics
The seven papers we reviewed were based on four trials
and were published between 2006 and 2016 (Table 1).
Six papers were extensions of three original RCTs. Sam-
ple size varied from 264 to 1714. The reviewed papers
are summarised in Table 2 and in the Supplementary
file. They included pregnant women from three different
countries: China, Australia and Nepal.
There was variation in the dose of iron supplementa-
tion and the gestation period at which supplementation
was initiated. Maternal iron supplementation varied
from 20 mg daily up to 300 mg daily (Table 1). Initiation
of iron supplementation varied from 11 weeks gestation
to 20 weeks gestation. Two RCTs were carried out in
areas where anaemia prevalence was high and one in an
area where it was low [11, 20, 25].
Three publications [26–28] were follow up studies of a
single RCT [29], with outcomes measured at different
stages in the development in the offspring, where
mothers had received iron supplementation. Similarly,
another two publications [11, 20] were based on another
RCT where mothers had received iron supplementation,
with outcomes measured at different stages in the devel-
opment in the offspring [25]. We excluded the study car-
ried out in Nepal for the meta-analysis [12]. This was
because in the original study there was a control group
receiving folic acid only supplementation, but this group
was not included in the follow up study [30]. In the trial
by Angulo Barroso et al., although there were four arms,
for this review we only considered the outcomes related
to the arm that received iron supplementation during
pregnancy and the control group [18]. The children who
received iron supplementation after birth were not in-
cluded in our analysis.
Anaemia prevalence
The prevalence of anaemia varied markedly across the
countries included in this review. A study linked to the
RCT in China gave a prevalence of anaemia undertaken
in the third trimester of gestation of 57% [29]. In Nepal
the baseline prevalence of anaemia in the study area was
more than 40% [30, 31]. In contrast the prevalence of
iron deficiency anaemia among those recruited in
Australia was 11% [25]. The estimated global prevalence
of anaemia in the general population is 24.8%, with an
estimated anaemia prevalence in preschool children of
47.4%, in pregnant women 41.8% and in non-pregnant
women 30.2% [32].
Quality of reporting
The quality of each of the studies was assessed according
to the Cochrane Risk of Bias tool. All the papers were
generally acceptable for most items in the quality assess-
ment matrix [19]. All studies used random sequence
generation and allocation concealment. In all, except
one paper [20] participants were blinded. The extent of
blinding of outcome assessment was unclear in three
studies [12, 20, 28]. There was very high loss to follow
Fig. 2 Risk of Bias Assessment
Table 2 Summary of parameters for the intervention and
control groups for the key studies
Authors Intervention group Control group
Mean SD N Mean SD N
Zhou et al. 2006 [11] 109 11 153 109 11 149
Parsons et al. 2008 [20] 8.6 6.3 132 9.2 5.9 132
Li et al. 2009 [27] 102.44 4.475 438 102.65 4.42 471
Chang et al. 2013 [26] 100.2 15.7 466 98 15.3 384
Li et al. 2015 [28] 88.98 12.69 562 89.82 14.07 604
Christian et al. 2010 [12] 51.7 8.5 103 48.2 10.2 177
Angulo Barroso et al. 2016 [18] 87.5 0.95 298 87.4 0.95 288
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up in three papers [12, 26, 27] and follow up rates were
unclear in two papers (Fig. 2). Analysis of primary out-
come data was undertaken on an ‘intention to treat’
basis in all except one study [26].
Mental development outcome
Different scales of measurement were used in different
studies, namely: Bayley’s Scale of Infant Development
(BSID); Stanford-Binet Intelligence Scale (SBIS);
Strengths and Difficulties Questionnaire (SDQ); Wechs-
ler Intelligence Scale for Children (WISC); Universal
Nonverbal Intelligence Test (UNVIT) and the Peabody
Developmental Motor Scale (PDMS). Although not ini-
tially designed for that purpose, the SDQ has been used
for studies to assess language, social, emotional prob-
lems and as a neurodevelopment assessment tool at
younger ages, and was therefore considered a valid tool
[33]. All the other tools have been used to assess
intelligence and cognitive function in children [34].
Effect of intervention
Three publications were not included in the meta-
analysis as they used the same participants at different
ages [20, 27, 28]. The RCT carried out in Nepal [12] was
not included as the intervention group was supple-
mented with both iron and folic acid. Three RCTs were
included in the meta-analysis and provided a weighted
mean difference of 0.54 units (95% CI -0.67 to 1.75), with
an overall effect size z = 0.87 (p = 0.38) and a heterogeneity
of 48% (p = 0.15). The level of heterogeneity was moderate
(I2 = 48%) and not statistically significant (Fig. 3). The
results suggest that routine (as opposed to targeted)
maternal iron supplementation does not have a statistically
significant effect on later neurodevelopment in offspring.
Discussion
The primary objective of this systematic review was to
determine whether antenatal iron supplementation pro-
vided any neurodevelopment benefit for offspring.
Among the seven eligible publications reviewed, only
one study was found that primarily focused on iron sup-
plementation in pregnancy and motor development of
offspring [18]. The other six publications were based on
RCTs where the original focus was on different objec-
tives and extensions of the initial trials were undertaken
to examine child neurodevelopmental effects. Our con-
clusion is that any effect of routine iron supplementation
on its own is likely to be very small.
We would suggest that the benefits of routine ante-
natal supplementation are likely to be related to the
underlying prevalence of anaemia in a given population.
The greatest effect was observed where anaemia preva-
lence was highest [26] and the least effect was observed
where anaemia prevalence was lowest [11].
There is evidence that the global prevalence of an-
aemia in pregnancy is falling, as a study carried out to
estimate the global mean haemoglobin concentration
among women of reproductive age (15–49 years) has
shown that anaemia prevalence decreased from 43% to
38% in pregnant women from 1995 to 2011 [35]. This
study suggests that in countries where the prevalence of
anaemia is low or falling, there may be a case for limit-
ing antenatal prescription of iron to women who are an-
aemic and have low iron stores.
An outstanding question, which merits further
research, is whether iron supplementation is best seen as
one of a cluster of micronutrients that need to be avail-
able during foetal growth to maximise neurodevelop-
ment, as two studies have provided some evidence to
support antenatal iron supplementation when provided
in conjunction with other micronutrients. In one study
carried out in Nepal, iron and folic acid supplementation
improved mean Universal Nonverbal Intelligence Test
scores on psychometric testing compared to a control
group [12]. A study in China also demonstrated a small
improvement in mental development raw scores at one
year of age in an iron supplementation group, compared
to a non-supplementation group [26]. Another study
showed a lower mental development index in children
born to mothers with iron deficiency anaemia during
pregnancy compared to those whose mothers were not
iron deficient during pregnancy [27]. As previously
stated, this may reflect the interplay between the avail-
ability of iron and other aetiological factors.
Although not include it in the meta analysis, a study
carried out in rural Vietnam demonstrated significant
Fig. 3 Forest plot of three RCTs included in a meta-analysis
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improvement in infant cognitive outcomes at six months
of age following twice weekly antenatal iron supplements
rather than daily supplements [36]. In an Indonesian
trial, supplementation with daily iron, weekly iron with
Vitamin A, and weekly iron alone was provided from
18 weeks of gestation until delivery followed by assess-
ment of cognitive and psychomotor development of in-
fants. The infants of all three supplemented groups had
similar mental and psychomotor development indices at
six and twelve months of age [25].
It is important to consider whether routine iron sup-
plementation could have adverse, as well as beneficial ef-
fects, as the possibility exists of adverse effects from
excessive iron supplementation in those who are not
iron deficient. Abnormal teacher rated peer relationship
problem subscale scores in the Strengths and Difficulties
Questionnaire were associated with iron supplementa-
tion in an Australian study (RR = 3.70; 95% CI 1.06 to
12.91; p = 0.026) [20]. In this study, the attrition rate was
almost 50% (only 112 out of 216 who were initially ran-
domized completed the study) and the results may have
been biased by differential drop out of healthy children.
The findings of this study therefore need interpreted
with caution. In summary, the meta-analysis of three
RCTs did not show a statistically significant benefit from
routine antenatal iron supplementation on the neurode-
velopment of offspring: weighted mean difference of 0.
54 units (95% CI 0.67 to 1.75).
Strengths and limitations
This review included RCTs without limiting the date of
publication. It provides a substantial update on a previ-
ous review, which had slightly different aims, but only
identified a single RCT [13]. The assessment of quality
in the RCTs was based on the methods described in the
original trials, bearing in mind that the original studies
were conducted with different objectives in some cases.
The tools used to assess the mental development of chil-
dren varied widely, as did the neurodevelopmental do-
mains that were evaluated, and some tools had not been
validated in the language into which they had been
translated.
A limitation of our study is that we may have missed
unpublished data or studies published in the grey litera-
ture. We may also have missed studies that were not
published in English. The majority of the included trials
were performed in Far Eastern countries and the
generalizability to other areas in the world requires some
caution.
The most appropriate follow up period for a study
such as this is difficult to determine. Assessment a week
after birth would clearly provide an inadequate follow
up period and follow up after the age of 12 years is prob-
ably affected by a wide range of other environmental
factors including puberty. Follow up at younger ages
might reduce heterogeneity, as most studies undertake
follow up within the first five years. However, follow up
at older ages is probably a better proxy for identifying
lifelong impacts of antenatal iron supplementation. A
case can be made for either approach. Sensitivity analysis
around age (not shown) did not indicate significant dif-
ferences in the outcome of the meta-analysis when the
age at which assessment was undertaken was varied. In
general, neurodevelopmental deficits present in early life
will be continued to some extent in later years so the
direction of any effects should be the same regardless of
age or precise developmental assessment method.
Assessment of neurodevelopmental function is challen-
ging. There is no universally recognized method of asses-
sing such development, and as a result different studies
inevitably use different tools. Stanford Binet Intelligence
Scale is used to assess cognitive ability and intelligence,
Bayley’s Scale of Infant Development is used for cognitive,
language, motor, social and emotional assessment and the
Peabody development scale is used for fine and gross
motor development assessment. Restricting our analysis
to only one dimension of neuro-development such as cog-
nitive function might have missed wider effects, but does
introduce conceptual heterogeneity.
It could be argued that this review should be restricted
to a descriptive analysis of the papers that have been iden-
tified, on the basis of the limited and diverse nature of the
assessment methods that were used. However, quantifica-
tion of results does add value, even when this needs to be
presented with appropriate caveats. On balance, we
believe that the advantages of including a range of studies
in our meta-analysis outweigh potential disadvantages and
a meta-analysis has therefore been provided.
Implication for research
It is possible to speculate that one micronutrient defi-
ciency is often associated with the presence of other
micronutrient deficiencies. As a result, future research
might assess whether larger benefits can be obtained by
the use of enriched diets with high multi-micronutrient
content, or multi-micronutrient supplementation, which
would address deficits across a wider range of enzymatic
pathways and potentially have a greater overall effect on
neurodevelopment in the foetal brain.
Conclusion
We have attempted to establish whether there are positive
neurodevelopmental outcomes from antenatal iron sup-
plementation and our conclusion is that there was little or
no evidence of benefit in routine use. Any effect appears
to be small. We consider that a large randomized con-
trolled trial of universal iron supplementation would be
required to substantially change our conclusions.
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